Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 404 for multiple

Edit search filters
  1. A Study for Long-Term Follow-up of Patients with Multiple Sclerosis who Participated in Previous Study of Alemtuzumab

    Scottsdale/Phoenix, AZ

  2. A Study to Evaluate AMG 701 in Subjects with Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ

  4. Novel Support Options in Autologous Stem Cell Transplant for Multiple Myeloma

    Scottsdale/Phoenix, AZ

  5. Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma

  6. A Study of the Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)

    Scottsdale/Phoenix, AZ

  7. Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

    Scottsdale/Phoenix, AZ

  8. A Study of Oral LGH447 in Patients with Relapsed and/or Refractory Multiple Myeloma

    Rochester, MN

  9. FT576 in Subjects With Multiple Myeloma

    Jacksonville, FL

  10. A Study to Evaluate Mesenchymal Stem Cells to Treat Multiple System Atrophy

    Rochester, MN

.

Mayo Clinic Footer